cisapride has been researched along with canertinib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Deng, H; Han, J; Huang, W; Li, B; Li, P; Li, Y; Liu, Y; Ma, C; Miao, H; Qi, W; Shao, J; Shen, J; Sun, X; Xia, G; Xiang, Z; Xu, J; Yu, Y; Zhang, J; Zhang, L; Zhang, Y | 1 |
1 other study(ies) available for cisapride and canertinib
Article | Year |
---|---|
A chemical tuned strategy to develop novel irreversible EGFR-TK inhibitors with improved safety and pharmacokinetic profiles.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Ether-A-Go-Go Potassium Channels; Humans; Lung Neoplasms; Mice, Inbred BALB C; Protein Kinase Inhibitors; Xenograft Model Antitumor Assays | 2014 |